All Posts: clinical trials
-
Georgetown Seeks Volunteers for New Immunotherapy Clinical Trial for Alzheimer’s
WASHINGTON — The Memory Disorders Program at Georgetown University is seeking volunteers to participate in an international clinical trial of a drug that, in an early phase study, has demonstrated promise in slowing mental decline in Alzheimer’s disease. Georgetown is the only institution in the greater Washington, DC, area offering access to the phase 3 study of the investigational immunotherapy drug aducanumab.
Category: News Release